Par Health Reports Third Quarter 2025 Financial Results and Provides Business Update

ST. LOUIS, Nov. 10, 2025 /PRNewswire/ -- Par Health, Inc. ("Par Health" or the "Company"), a generic pharmaceuticals and sterile injectables company committed to delivering essential medicines, today reported its financial results for the third quarter of 2025. As was announced in a...

Read More